Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry.
Gabiña PM, Gleisner KS, Cremonesi M, Stokke C, Flux G, Cicone F, Konijnenberg M, Aldridge M, Sandstrom M, Chiesa C, Paphiti M, Hippeläinen E, Uribe C, Solny P, Gnesin S, Bernhardt P, Chouin N, Costa PF, Glatting G, Verburg F, Gear J. Gabiña PM, et al. Among authors: verburg f. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2595-2604. doi: 10.1007/s00259-023-06215-2. Eur J Nucl Med Mol Imaging. 2023. PMID: 37129712 No abstract available.
The "reset button" revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients.
Verburg FA, Luster M, Giovanella L, Lassmann M, Chiesa C, Chouin N, Flux G; EANM Thyroid, Radiation Protection and Dosimetry Committees. Verburg FA, et al. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):915-917. doi: 10.1007/s00259-017-3649-9. Epub 2017 Feb 16. Eur J Nucl Med Mol Imaging. 2017. PMID: 28210770 No abstract available.
I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?
Verburg FA, Giovanella L, Iakovou I, Konijnenberg MW, Langsteger W, Lassmann M, Mihailovic J, Luster M. Verburg FA, et al. Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2247-2249. doi: 10.1007/s00259-018-4184-z. Epub 2018 Oct 8. Eur J Nucl Med Mol Imaging. 2018. PMID: 30298378 No abstract available.
Errare humanum est, sed in errare perseverare diabolicum: methodological errors in the assessment of the relationship between I-131 therapy and possible increases in the incidence of malignancies.
Verburg FA, Hoffmann M, Iakovou I, Konijnenberg MW, Mihailovic J, Gabina PM, Ovčariček PP, Reiners C, Vrachimis A, Zerdoud S, Giovanella L, Luster M. Verburg FA, et al. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):519-522. doi: 10.1007/s00259-019-04580-5. Eur J Nucl Med Mol Imaging. 2020. PMID: 31807882 No abstract available.
The EANM practice guidelines for parathyroid imaging.
Petranović Ovčariček P, Giovanella L, Carrió Gasset I, Hindié E, Huellner MW, Luster M, Piccardo A, Weber T, Talbot JN, Verburg FA. Petranović Ovčariček P, et al. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2801-2822. doi: 10.1007/s00259-021-05334-y. Epub 2021 Apr 10. Eur J Nucl Med Mol Imaging. 2021. PMID: 33839893 Free PMC article.
278 results